Tech Company Financing Transactions
Frontera Therapeutics Funding Round
Boyu Capital, Creacion Ventures and OrbiMed joined a $160 million Series B funding round for Frontera Therapeutics. The round was announced on 7/20/2022.
Transaction Overview
Company Name
Announced On
7/20/2022
Transaction Type
Venture Equity
Amount
$160,000,000
Round
Series B
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Patriot Park
Bedford, MA 01730
USA
Bedford, MA 01730
USA
Phone
Website
Email Address
Overview
Frontera's mission is to develop the best gene therapy medicines possible to improve the lives of patients across multiple disease areas. To achieve this goal, we solve the problem of disparate teams addressing isolated problems independently, which results in potential R&D pitfalls and limits the success of gene therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yong Dai
Browse more venture capital transactions:
Prev: 7/20/2022: Dot Compliance venture capital transaction
Next: 7/20/2022: Proteus Motion venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs